Author:
Tolboom Nelleke,Berendse Henk W,Leysen Josee E,Yaqub Maqsood,van Berckel Bart NM,Schuit Robert C,Ponsen Mirthe M,Bakker Esther,Hoetjes Nikie J,Windhorst Albert D,Carlsson Maria L,Lammertsma Adriaan A,Carlsson Arvid
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference44 articles.
1. Alakurtti K, Johansson JJ, Tuokkola T, Nägren K, Rinne JO (2013). Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [11C]raclopride and high-resolution positron emission tomography. Neuroimage 82: 252–259.
2. Bressan RA, Erlandsson K, Spencer EP, Ell PJ, Pilowsky LS (2004). Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients. Psychopharmacology (Berl) 175: 367–373.
3. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H et al (1997). Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 38: 1614–1623.
4. Burstein ES, Carlsson ML, Owens M, Ma JN, Schiffer HH, Carlsson A et al (2011). II. In vitro evidence that (−)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors. J Neural Transm 118: 1523–1533.
5. Carlsson A, Carlsson ML (2006). A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues Clin Neurosci 8: 137–142.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献